Aspirin
- Generic Name
- Aspirin
- Brand Names
- Aggrenox, Alka-seltzer, Alka-seltzer Fruit Chews, Anacin, Arthriten Inflammatory Pain, Ascomp, Aspi-cor, Aspir-low, Bayer Aspirin, Bayer Womens, Bc Arthritis, Bc Original Formula, Bufferin, Duoplavin, Durlaza, Ecotrin, Ecpirin, Endodan Reformulated May 2009, Equagesic, Exaprin, Excedrin, Excedrin PM Triple Action, Fasprin, Fiorinal, Goody's Body Pain, Goody's Extra Strength, Goody's PM, Miniprin, Norgesic, Norgesic Forte, Orphengesic, Pamprin Max Formula, Robaxisal, ST. Joseph Aspirin, Stanback Headache Powder Reformulated Jan 2011, Trianal, Trianal C, Vanquish, Vazalore, Yosprala
- Drug Type
- Small Molecule
- Chemical Formula
- C9H8O4
- CAS Number
- 50-78-2
- Unique Ingredient Identifier
- R16CO5Y76E
- Background
Also known as Aspirin, acetylsalicylic acid (ASA) is a commonly used drug for the treatment of pain and fever due to various causes. Acetylsalicylic acid has both anti-inflammatory and antipyretic effects. This drug also inhibits platelet aggregation and is used in the prevention of blood clots stroke, and myocardial infarction (MI) .
...
- Indication
Pain, fever, and inflammation
...
- Associated Conditions
- Acute Coronary Syndrome (ACS), Anxiety, Atherothrombotic cerebral infarction, Cardiovascular Disease (CVD), Cardiovascular Events, Cardiovascular Mortality, Colorectal Adenomas, Colorectal Cancer, Common Cold, Coronary artery reocclusion, Death, Dyspeptic signs and symptoms, Fever, Flu caused by Influenza, Headache, Heterozygous Familial Hypercholesterolemia (HeFH), Inflammation, Juvenile Idiopathic Arthritis (JIA), Major Adverse Cardiovascular and Cerebrovascular Events (MACCE), Menstrual Pain, Migraine, Morbidity, Mucocutaneous Lymph Node Syndrome, Muscle Contraction, Myalgia, Myocardial Infarction, Myocardial Infarction (MI), first occurrence, Neuropathic Pain, Pain, Pain caused by Common Cold, Pain caused by Rheumatism, Pericarditis, Polycythemia Vera (PV), Pre-Eclampsia, Rheumatism, Rheumatoid Arthritis, Rhino Sinusitis, Severe Pain, Spondyloarthropathies, Stroke, Systemic Lupus Erythematosus, Tension Headache, Thromboembolism, Thrombosis, Toothache, Transient Ischemic Attack, Vascular Death, Venous Thromboembolism, Acute Inflammation, Articular inflammation, Atherothrombotic events, Death caused by Myocardial Infarction, Fever or influenza-like illness, Moderate Pain, Recurrent Ischemic Stroke
- Associated Therapies
- Anti-platelet Therapy, Hemodialysis Treatment, Secondary Prevention
A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression
- Conditions
- Interventions
- First Posted Date
- 2007-06-05
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- Peter MacCallum Cancer Centre, Australia
- Target Recruit Count
- 150
- Registration Number
- NCT00482261
- Locations
- 🇦🇺
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Anticoagulant Therapy During Pacemaker Implantation
- Conditions
- Interventions
- First Posted Date
- 2007-05-28
- Last Posted Date
- 2012-09-17
- Lead Sponsor
- University of Turku
- Target Recruit Count
- 447
- Registration Number
- NCT00479362
- Locations
- 🇫🇮
Turku University Hospital, Turku, Finland
Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
- Conditions
- Interventions
- First Posted Date
- 2007-05-17
- Last Posted Date
- 2014-07-02
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 122
- Registration Number
- NCT00474903
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Effect of Aspirin on Mammogram Density in Healthy Postmenopausal Women With a Moderate or High Level of Breast Density
- First Posted Date
- 2007-05-07
- Last Posted Date
- 2010-11-15
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 144
- Registration Number
- NCT00470561
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer
- Conditions
- Interventions
- First Posted Date
- 2007-05-03
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 79
- Registration Number
- NCT00468910
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
The Effect of Serum LDL Lowering on Aspirin Resistance
- Conditions
- First Posted Date
- 2007-04-27
- Last Posted Date
- 2013-02-20
- Lead Sponsor
- Ziv Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT00466154
- Locations
- 🇮🇱
Internal Medicine Department A ,Ziv Goverment Hospital, Safed, Israel
The Indian POLYCAP Study (TIPS)
- First Posted Date
- 2007-03-06
- Last Posted Date
- 2010-09-23
- Lead Sponsor
- St. John's Research Institute
- Target Recruit Count
- 2050
- Registration Number
- NCT00443794
- Locations
- 🇮🇳
MGM, Indore, Madhya Pradesh, India
🇮🇳Sri Ganga Ram Hospital, New Delhi, Delhi, India
🇮🇳Fortis Hospital, Noida, Delhi, India
A Parallel Group Study to Compare the Gastroprotective Effects of PA 325 Versus 81 mg Enteric Coated Aspirin
- Conditions
- First Posted Date
- 2007-03-01
- Last Posted Date
- 2009-01-12
- Lead Sponsor
- POZEN
- Target Recruit Count
- 80
- Registration Number
- NCT00441519
- Locations
- 🇺🇸
POZEN, Chapel Hill, North Carolina, United States
🇨🇦MDS Pharma Services, Montreal, Quebec, Canada
To Compare the Gastroprotective Effects and Pharmacokinetic Profile of PA Versus Enteric-Coated Aspirin
- Conditions
- First Posted Date
- 2007-03-01
- Last Posted Date
- 2007-03-01
- Lead Sponsor
- POZEN
- Target Recruit Count
- 80
- Registration Number
- NCT00442052
- Locations
- 🇨🇦
MDS Pharma Services, Montreal, Quebec, Canada
🇺🇸POZEN, Chapel Hill, North Carolina, United States
Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients
- Conditions
- First Posted Date
- 2007-01-29
- Last Posted Date
- 2007-01-29
- Lead Sponsor
- Hospital de Clinicas de Porto Alegre
- Target Recruit Count
- 20
- Registration Number
- NCT00427271
- Locations
- 🇧🇷
Hospital de Clínicas de Porto Aelgre, Porto Alegre, RS, Brazil
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.